Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer

NCT06945978 is registered in ClinicalTrials.gov with Benedito Mauro Rossi as lead sponsor.

NCT NCT06945978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06945978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer
Lead sponsor
Benedito Mauro Rossi
Phase
Observational
Overall status
Recruiting
Start date
January 21, 2025
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epigenetic, metastasis, pancreatic cancer